The activity of netilmicin and tobramycin against Pseudomonas aeruginosa was assessed in vitro in the presence of constant and exponentially declining concentra-tions, and in mice in an experimental thigh infection. The activity in vitro at constant concentrations was expressed as the maximal killing rate (ER) during 3 h of exposure. On the basis of the quantitative relation between £(R) and the drug concentration, the numbers of cfu expected at consecutive times, at constant as well as at declining concentrations, were predicted. The relationship between observed numbers and predicted values of ERt were similar under both conditions for both drugs. On the same basis the numbers of cfu expected in the experimental thigh infection were predi...
During an ongoing randomized, prospective study comparing the efficacy and safety of netilmicin give...
Tobramycin, a new aminoglycoside antibiotic, was shown to be effective in vitroagainst Pseudomonas, ...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...
The bactericidal efficacy of amikacin, isepamicin and netilmicin was studied against Pseudomonas aer...
The susceptibilities of various clinical isolates to tobramycin were studied, and the applicability ...
Synergism between two antibiotics is usually tested by a checkerboard titration technique, or by tim...
The efficacy of ceftazidime, piperacillin, tobramycin and ticarcillin was tested in vitro against 10...
Time-survival studies were conducted to estimate the elfects of azlocillin and tobramycin on Pseudom...
This study aimed to systematically identify the aminoglycoside concentrations required for synergy w...
An effort was made to elucidate the limits of drug-activity tests in small animals. Human plasma kin...
Bacterial resistance is among the most serious threats to human health globally, andmany bacterial i...
Netilmicin, a new semisynthetic aminoglycoside, was evaluated in the therapy of 33 episodes of infec...
Biofilms and infectious process may alter free antimicrobial concentrations at the site of infection...
The minimum inhibitory concentrations (MICs) of 11 aminocyclitol antibiotics were determined for 773...
The antibacterial activity of fosfomycin-tobramycin combination was studied by time-kill assay in ei...
During an ongoing randomized, prospective study comparing the efficacy and safety of netilmicin give...
Tobramycin, a new aminoglycoside antibiotic, was shown to be effective in vitroagainst Pseudomonas, ...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...
The bactericidal efficacy of amikacin, isepamicin and netilmicin was studied against Pseudomonas aer...
The susceptibilities of various clinical isolates to tobramycin were studied, and the applicability ...
Synergism between two antibiotics is usually tested by a checkerboard titration technique, or by tim...
The efficacy of ceftazidime, piperacillin, tobramycin and ticarcillin was tested in vitro against 10...
Time-survival studies were conducted to estimate the elfects of azlocillin and tobramycin on Pseudom...
This study aimed to systematically identify the aminoglycoside concentrations required for synergy w...
An effort was made to elucidate the limits of drug-activity tests in small animals. Human plasma kin...
Bacterial resistance is among the most serious threats to human health globally, andmany bacterial i...
Netilmicin, a new semisynthetic aminoglycoside, was evaluated in the therapy of 33 episodes of infec...
Biofilms and infectious process may alter free antimicrobial concentrations at the site of infection...
The minimum inhibitory concentrations (MICs) of 11 aminocyclitol antibiotics were determined for 773...
The antibacterial activity of fosfomycin-tobramycin combination was studied by time-kill assay in ei...
During an ongoing randomized, prospective study comparing the efficacy and safety of netilmicin give...
Tobramycin, a new aminoglycoside antibiotic, was shown to be effective in vitroagainst Pseudomonas, ...
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (C...